HomeCompareSYIEY vs MRK

SYIEY vs MRK: Dividend Comparison 2026

SYIEY yields 1.58% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $29.4K in total portfolio value
10 years
SYIEY
SYIEY
● Live price
1.58%
Share price
$21.48
Annual div
$0.34
5Y div CAGR
21.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.4K
Annual income
$1,437.50
Full SYIEY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SYIEY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYIEYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYIEY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYIEY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYIEY
Annual income on $10K today (after 15% tax)
$134.44/yr
After 10yr DRIP, annual income (after tax)
$1,221.88/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,106.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYIEY + MRK for your $10,000?

SYIEY: 50%MRK: 50%
100% MRK50/50100% SYIEY
Portfolio after 10yr
$42.1K
Annual income
$5,617.82/yr
Blended yield
13.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SYIEY
Analyst Ratings
2
Buy
3
Hold
Consensus: Hold
Altman Z
3.1
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYIEY buys
2
MRK buys
0
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$SYIEY▼ Sell$1,001 - $15,0002024-06-21
Daniel Goldman🏢 House$SYIEY▼ Sell$1,001 - $15,0002023-07-10
Daniel Goldman🏢 House$SYIEY▲ Buy$1,001 - $15,0002023-03-31
Peter Meijer🏢 House$SYIEY▼ Sell$15,001 - $50,0002021-02-17
Greg Gianforte🏢 House$SYIEY▲ Buy$15,001 - $50,0002020-08-04
Greg Gianforte🏢 House$SYIEY▼ Sell$15,001 - $50,0002020-01-13
Donna Shalala🏢 House$SYIEY▼ Sell$1,001 - $15,0002019-06-24
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYIEYMRK
Forward yield1.58%2.76%
Annual dividend / share$0.34$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR21.3%32.7%
Portfolio after 10y$27.4K$56.8K
Annual income after 10y$1,437.50$9,798.13
Total dividends collected$6.3K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: SYIEY vs MRK ($10,000, DRIP)

YearSYIEY PortfolioSYIEY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,892$191.86$11,206$366.19$314.00MRK
2$11,891$236.90$12,650$502.35$759.00MRK
3$13,017$293.20$14,407$694.19$1.4KMRK
4$14,292$363.85$16,585$967.82$2.3KMRK
5$15,745$452.88$19,342$1,363.89$3.6KMRK
6$17,413$565.61$22,913$1,947.19$5.5KMRK
7$19,341$709.12$27,662$2,823.89$8.3KMRK
8$21,588$892.90$34,159$4,173.35$12.6KMRK
9$24,229$1,129.82$43,337$6,308.80$19.1KMRK
10$27,362$1,437.50$56,776$9,798.13$29.4KMRK

SYIEY vs MRK: Complete Analysis 2026

SYIEYStock

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, aroma molecules, cosmetic ingredients, and mint flavors, as well as specific application processes for such substances. This segment's products are used by manufacturers of perfumes, personal care and cosmetic products, cleaning products, detergents, air fresheners, and oral care products. It operates in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. Symrise AG was founded in 1874 and is headquartered in Holzminden, Germany.

Full SYIEY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SYIEY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYIEY vs SCHDSYIEY vs JEPISYIEY vs OSYIEY vs KOSYIEY vs MAINSYIEY vs JNJSYIEY vs ABBVSYIEY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.